SE8703308L - Terapeutiskt medel for behandling av sjukdomar forbundna med cerebral ischemi - Google Patents

Terapeutiskt medel for behandling av sjukdomar forbundna med cerebral ischemi

Info

Publication number
SE8703308L
SE8703308L SE8703308A SE8703308A SE8703308L SE 8703308 L SE8703308 L SE 8703308L SE 8703308 A SE8703308 A SE 8703308A SE 8703308 A SE8703308 A SE 8703308A SE 8703308 L SE8703308 L SE 8703308L
Authority
SE
Sweden
Prior art keywords
treatment
cerebral
ischemistry
therapeutic agent
diseases connected
Prior art date
Application number
SE8703308A
Other languages
Unknown language ( )
English (en)
Other versions
SE502323C2 (sv
SE8703308D0 (sv
Inventor
Y Noda
H Nabata
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of SE8703308D0 publication Critical patent/SE8703308D0/sv
Publication of SE8703308L publication Critical patent/SE8703308L/sv
Publication of SE502323C2 publication Critical patent/SE502323C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE8703308A 1986-08-27 1987-08-26 Användning av N-(2-hydroxietyl)nikotinamidnitrat eller ett farmaceutiskt godtagbart salt därav för framställning av ett läkemedel aktivt för behandling av sjukdomar förbundna med cerebral ischemi SE502323C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19879686 1986-08-27

Publications (3)

Publication Number Publication Date
SE8703308D0 SE8703308D0 (sv) 1987-08-26
SE8703308L true SE8703308L (sv) 1988-02-28
SE502323C2 SE502323C2 (sv) 1995-10-02

Family

ID=16397046

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703308A SE502323C2 (sv) 1986-08-27 1987-08-26 Användning av N-(2-hydroxietyl)nikotinamidnitrat eller ett farmaceutiskt godtagbart salt därav för framställning av ett läkemedel aktivt för behandling av sjukdomar förbundna med cerebral ischemi

Country Status (22)

Country Link
US (1) US4870090A (sv)
JP (1) JPH07121863B2 (sv)
KR (1) KR950002151B1 (sv)
AU (1) AU603375B2 (sv)
BE (1) BE1003959A5 (sv)
CA (1) CA1302888C (sv)
CH (1) CH672069A5 (sv)
DE (1) DE3728499A1 (sv)
DK (1) DK171392B1 (sv)
FI (1) FI873727A (sv)
FR (1) FR2605222B1 (sv)
GB (1) GB2195532B (sv)
HK (1) HK64993A (sv)
IE (1) IE60601B1 (sv)
IT (1) IT1211477B (sv)
LU (1) LU86973A1 (sv)
NL (1) NL8701994A (sv)
NO (1) NO873571L (sv)
NZ (1) NZ221564A (sv)
SE (1) SE502323C2 (sv)
SG (1) SG52393G (sv)
ZA (1) ZA876401B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736529A (en) * 1996-03-22 1998-04-07 Neurocal International Inc. Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
CN107773545A (zh) * 2016-08-29 2018-03-09 烟台益诺依生物医药科技有限公司 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1562962A (en) * 1976-04-02 1980-03-19 Chugai Pharmaceutical Co Ltd Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
EP0223811A1 (en) * 1985-05-22 1987-06-03 Beecham Group Plc Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
US4696934A (en) * 1986-01-10 1987-09-29 Warner-Lambert Company Method for using nifedipine for treating stroke
EP0259309A1 (en) * 1986-03-14 1988-03-16 Medical College Of Wisconsin Research Foundation, Inc. Method of treatment and prevention of cerebral vasospasms

Also Published As

Publication number Publication date
JPH07121863B2 (ja) 1995-12-25
IT8767725A0 (it) 1987-08-21
DE3728499A1 (de) 1988-03-03
NO873571D0 (no) 1987-08-24
AU7731187A (en) 1988-03-03
CH672069A5 (sv) 1989-10-31
GB8720219D0 (en) 1987-10-07
SG52393G (en) 1993-08-06
ZA876401B (en) 1988-04-27
LU86973A1 (fr) 1987-12-16
SE502323C2 (sv) 1995-10-02
IE60601B1 (en) 1994-07-27
DK441987A (da) 1988-02-28
GB2195532B (en) 1990-05-23
CA1302888C (en) 1992-06-09
DK171392B1 (da) 1996-10-14
US4870090A (en) 1989-09-26
KR950002151B1 (ko) 1995-03-14
BE1003959A5 (fr) 1992-07-22
FR2605222B1 (fr) 1991-02-22
IT1211477B (it) 1989-11-03
DK441987D0 (da) 1987-08-25
NO873571L (no) 1988-02-29
NZ221564A (en) 1999-08-30
FI873727A (fi) 1988-02-28
NL8701994A (nl) 1988-03-16
FR2605222A1 (fr) 1988-04-22
FI873727A0 (fi) 1987-08-27
IE872218L (en) 1988-02-27
SE8703308D0 (sv) 1987-08-26
KR880002525A (ko) 1988-05-09
JPS63152317A (ja) 1988-06-24
HK64993A (en) 1993-07-16
AU603375B2 (en) 1990-11-15
GB2195532A (en) 1988-04-13

Similar Documents

Publication Publication Date Title
SE7903186L (sv) Cerebralverksamt medel
NO160850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer.
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO912758L (no) Anvendelse av det virksomme stoffet flupirtin for bekjempelse av muskelspenninger.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO882406L (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
NO864130D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater.
NO885598D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser.
NO900697D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater.
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
EP0396748A4 (en) Agent for treating ischemic brain trouble
SE8703308L (sv) Terapeutiskt medel for behandling av sjukdomar forbundna med cerebral ischemi
NO884175L (no) Fremgangsmaate for fremstilling av terapeutiske aktive heterocykliske derivater.
NO167456C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre
NO172495C (no) Fremgangsmaate for fremstilling av terapeutisk aktive, ikke-mettede aminosyreforbindelser
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO881884D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO167739C (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive ginkolid-derivater.
DK532087A (da) Farmaceutiske praeparater til behandling af hjernelidelser paa funktional og organisk basis
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DK320081A (da) Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater

Legal Events

Date Code Title Description
NUG Patent has lapsed